• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔黏膜下纤维化的病因学因素、疾病进展及恶性转化相关研究的最新进展

An update on studies on etiological factors, disease progression, and malignant transformation in oral submucous fibrosis.

作者信息

Bari Samiha, Metgud Rashmi, Vyas Zankhana, Tak Aniruddh

机构信息

Department of Oral and Maxillofacial Pathology, Pacific Dental College and Hospital, Udaipur, Rajasthan, India.

出版信息

J Cancer Res Ther. 2017 Jul-Sep;13(3):399-405. doi: 10.4103/0973-1482.179524.

DOI:10.4103/0973-1482.179524
PMID:28862199
Abstract

Worldwide estimates of oral submucous fibrosis (OSMF) show a confinement to Indians and Southeast Asians. In India, the prevalence of OSMF has increased over the past four decades from 0.03% to 6.42%. The condition is well recognized for its malignant potential rate of 7-30%. The condition has a multifactorial etiology and may remain either stationary or become severe, leaving an individual physically challenged both physically and psychologically. Hence, the study aims at reviewing studies done on various etiological factors leading to its onset. Their analysis may serve as an adjunct in defining the broad spectrum of the causation of this potentially malignant disorder.

摘要

全球范围内对口腔黏膜下纤维化(OSMF)的估计表明,该病主要局限于印度人和东南亚人。在印度,过去四十年来OSMF的患病率从0.03%上升至6.42%。该疾病因其7%-30%的恶变率而广为人知。其病因是多因素的,病情可能保持稳定或加重,给患者带来身体和心理上的双重挑战。因此,本研究旨在回顾关于导致其发病的各种病因的研究。对这些研究的分析可能有助于明确这种潜在恶性疾病的广泛病因。

相似文献

1
An update on studies on etiological factors, disease progression, and malignant transformation in oral submucous fibrosis.口腔黏膜下纤维化的病因学因素、疾病进展及恶性转化相关研究的最新进展
J Cancer Res Ther. 2017 Jul-Sep;13(3):399-405. doi: 10.4103/0973-1482.179524.
2
A systematic review on the mechanisms of malignant transformation of oral submucous fibrosis.口腔黏膜下纤维性变恶性转化机制的系统评价
Eur J Cancer Prev. 2020 Sep;29(5):470-473. doi: 10.1097/CEJ.0000000000000575.
3
Oral submucous fibrosis: An update on pathophysiology of malignant transformation.口腔黏膜下纤维性变:恶性转化的病理生理学更新。
J Oral Pathol Med. 2017 Jul;46(6):413-417. doi: 10.1111/jop.12582. Epub 2017 May 6.
4
Oral submucous fibrosis: An update on current theories of pathogenesis.口腔黏膜下纤维性变:发病机制的最新理论。
J Oral Pathol Med. 2017 Jul;46(6):406-412. doi: 10.1111/jop.12581. Epub 2017 May 4.
5
Oral submucous fibrosis-an increasing global healthcare problem.口腔黏膜下纤维化——一个日益严重的全球医疗保健问题。
J Oral Pathol Med. 2017 Jul;46(6):405. doi: 10.1111/jop.12580.
6
Oral submucous fibrosis: review on mechanisms of malignant transformation.口腔黏膜下纤维化:恶性转化机制综述
Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Aug;122(2):192-9. doi: 10.1016/j.oooo.2015.12.018. Epub 2016 Apr 19.
7
Oral submucous fibrosis: a historical perspective and a review on etiology and pathogenesis.口腔黏膜下纤维化:历史回顾及病因与发病机制综述
Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Aug;122(2):178-91. doi: 10.1016/j.oooo.2016.04.003. Epub 2016 Apr 19.
8
Oral submucous fibrosis: a clinicopathologic review of 205 cases in Indians.口腔黏膜下纤维化:205例印度患者的临床病理回顾
Oral Maxillofac Surg. 2011 Mar;15(1):15-9. doi: 10.1007/s10006-010-0225-x.
9
Oral submucous fibrosis: An enigmatic morpho-insight.口腔黏膜下纤维化:一种神秘的形态学见解。
J Cancer Res Ther. 2019 Jul-Sep;15(3):463-469. doi: 10.4103/jcrt.JCRT_522_17.
10
Molecular Pathology of Malignant Transformation of Oral Submucous Fibrosis.口腔黏膜下纤维化恶性转化的分子病理学
J Environ Pathol Toxicol Oncol. 2016;35(3):193-205. doi: 10.1615/JEnvironPatholToxicolOncol.2016014024.

引用本文的文献

1
Colchicine in the Management of Oral Submucous Fibrosis - A Systematic Review and GRADE Assessment.秋水仙碱在口腔黏膜下纤维化治疗中的应用——一项系统评价与GRADE评估
J Pharm Bioallied Sci. 2024 Dec;16(Suppl 5):S4289-S4298. doi: 10.4103/jpbs.jpbs_1313_24. Epub 2025 Jan 30.
2
Hindi Translation of Oral Health-Related Quality of Life (OHRQoL) Questionnaire and its Validation for Oral Submucous Fibrosis Patients: A Pilot Study.口腔健康相关生活质量(OHRQoL)问卷的印地语翻译及其在口腔黏膜下纤维化患者中的效度验证:一项初步研究
J Maxillofac Oral Surg. 2024 Oct;23(5):1275-1281. doi: 10.1007/s12663-023-01927-2. Epub 2023 Jun 26.
3
To Estimate and Compare the Level of Serum Immunoglobulin A in Patients of Oral Submucous Fibrosis, Leukoplakia, and Control Group.
评估和比较口腔黏膜下纤维化患者、白斑患者及对照组的血清免疫球蛋白A水平。
J Pharm Bioallied Sci. 2024 Jul;16(Suppl 3):S1987-S1990. doi: 10.4103/jpbs.jpbs_1295_23. Epub 2024 Apr 3.
4
Computational analysis of phytocompounds in for its antifibrotic and drug-likeness properties - Herb to drug study.用于抗纤维化和类药物特性的植物化合物的计算分析——从草药到药物的研究。
Heliyon. 2024 Jun 27;10(13):e33762. doi: 10.1016/j.heliyon.2024.e33762. eCollection 2024 Jul 15.
5
Up regulation of serum L fucose glycoprotein as a diagnostic biomarker for dysplasia in oral sub mucous fibrosis patients.血清L-岩藻糖糖蛋白上调作为口腔黏膜下纤维化患者发育异常的诊断生物标志物
Heliyon. 2024 Jan 9;10(2):e24211. doi: 10.1016/j.heliyon.2024.e24211. eCollection 2024 Jan 30.
6
A novel approach to develop an animal model for oral submucous fibrosis.一种开发口腔黏膜下纤维化动物模型的新方法。
Med Oncol. 2022 Aug 16;39(11):162. doi: 10.1007/s12032-022-01760-6.
7
Clinical Assessment of Efficacy of Omega 3 in Oral Submucous Fibrosis Patients - A Randomized Controlled Trial.临床评估欧米伽 3 对口腔黏膜下纤维性变患者疗效的随机对照试验。
Asian Pac J Cancer Prev. 2022 Apr 1;23(4):1185-1192. doi: 10.31557/APJCP.2022.23.4.1185.
8
Correlation of Clinical Features in Oral Submucous Fibrosis: A 9-Year Retrospective Study.口腔黏膜下纤维性变的临床特征相关性:一项 9 年回顾性研究。
Ethiop J Health Sci. 2022 Jan;32(1):137-144. doi: 10.4314/ejhs.v32i1.15.
9
Molecular Mechanisms of Malignant Transformation of Oral Submucous Fibrosis by Different Betel Quid Constituents-Does Fibroblast Senescence Play a Role?不同槟榔成分致口腔黏膜下纤维性变恶性转化的分子机制——成纤维细胞衰老是否起作用?
Int J Mol Sci. 2022 Jan 31;23(3):1637. doi: 10.3390/ijms23031637.
10
Comparative Evaluation of Reconstructive Methods in Oral Submucous Fibrosis.口腔黏膜下纤维化重建方法的比较评估
J Maxillofac Oral Surg. 2021 Dec;20(4):597-606. doi: 10.1007/s12663-020-01493-x. Epub 2021 Jan 23.